CANF - Can-Fite BioPharma Ltd.

NYSE American - Nasdaq Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue3,820789165162
Cost of Revenue----
Gross Profit3,820789165162
Operating Expenses
Research Development6,0245,0556,0673,857
Selling General and Administrative3,2102,9192,7932,782
Non Recurring----
Total Operating Expenses9,2347,9748,8606,639
Operating Income or Loss-5,414-7,185-8,695-6,477
Income from Continuing Operations
Total Other Income/Expenses Net-1,153781331-27
Earnings Before Interest and Taxes-5,414-7,185-8,695-6,477
Interest Expense-427-427-427-427
Income Before Tax-6,567-6,404-8,364-6,504
Income Tax Expense429295
Minority Interest--42129.347
Net Income From Continuing Ops-6,571-6,433-8,393-6,509
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,571-6,339-8,257-6,243
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,571-6,339-8,257-6,243